Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 304

1.

Organs at risk's tolerance and dose limits for head and neck cancer re-irradiation: A literature review.

Dionisi F, Fiorica F, D'Angelo E, Maddalo M, Giacomelli I, Tornari E, Rosca A, Vigo F, Romanello D, Cianchetti M, Tommasino F, Massaccesi M, Orlandi E.

Oral Oncol. 2019 Sep 16;98:35-47. doi: 10.1016/j.oraloncology.2019.08.017. [Epub ahead of print] Review.

PMID:
31536844
2.

Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2,N0-1): A review.

Ivaldi E, Di Mario D, Paderno A, Piazza C, Bossi P, Iacovelli NA, Incandela F, Locati L, Fallai C, Orlandi E.

Crit Rev Oncol Hematol. 2019 Aug 31;143:67-75. doi: 10.1016/j.critrevonc.2019.08.003. [Epub ahead of print] Review.

PMID:
31499275
3.

Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy.

Ferella L, Cavallo A, Miceli R, Iacovelli NA, Giandini T, Pignoli E, Calareso G, Bossi P, Resteghini C, Gravina GL, Nicolai P, Castelnuovo P, Piazza C, Licitra L, Fallai C, Orlandi E.

Tumori. 2019 Aug 27:300891619868006. doi: 10.1177/0300891619868006. [Epub ahead of print]

PMID:
31451102
4.

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.

Crugnola M, Castagnetti F, Breccia M, Ferrero D, Trawinska MM, Abruzzese E, Annunziata M, Stagno F, Tiribelli M, Binotto G, Bonifacio M, Fava C, Iurlo A, Bucelli C, Mansueto G, Gozzini A, Falzetti F, Montefusco E, Crisà E, Gugliotta G, Russo S, Cedrone M, RussoRossi A, Pregno P, Isidori A, Mauro E, Atelda R, Giglio G, Celesti F, Sorà F, Storti S, D'Addosio A, Galimberti S, Orlandi E, Calistri E, Bocchia M, Cavazzini F, Rege Cambrin G, Orofino N, Luciano L, Sgherza N, Rosti G, Latagliata R, Capodanno I.

Ann Hematol. 2019 Oct;98(10):2329-2338. doi: 10.1007/s00277-019-03767-y. Epub 2019 Aug 7.

PMID:
31392461
5.

Locally advanced epithelial sinonasal tumors: The impact of multimodal approach.

Orlandi E, Cavalieri S, Granata R, Nicolai P, Castelnuovo P, Piazza C, Schreiber A, Turri-Zanoni M, Quattrone P, Miceli R, Infante G, Sessa F, Facco C, Calareso G, Iacovelli NA, Mattavelli D, Paderno A, Resteghini C, Locati LD, Licitra L, Bossi P.

Laryngoscope. 2019 Aug 1. doi: 10.1002/lary.28202. [Epub ahead of print]

PMID:
31369156
6.

Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma.

Locati LD, Serafini MS, Iannò MF, Carenzo A, Orlandi E, Resteghin C, Cavalieri S, Bossi P, Canevari S, Licitra L, De Cecco L.

Cancers (Basel). 2019 Jul 26;11(8). pii: E1057. doi: 10.3390/cancers11081057.

7.

Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract.

Locati LD, Cavalieri S, Bergamini C, Resteghini C, Alfieri S, Calareso G, Bossi P, Perrone F, Tamborini E, Quattrone P, Granata R, Galbiati D, Platini F, Orlandi E, Mariani L, Licitra L.

Head Neck. 2019 Oct;41(10):3670-3676. doi: 10.1002/hed.25891. Epub 2019 Jul 29.

PMID:
31355973
8.

Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.

Orlandi E, Bonomo P, Ferella L, D'Angelo E, Maddalo M, Alterio D, Infante G, Bacigalupo A, Argenone A, Iacovelli NA, Desideri I, Meduri B, Triggiani L, Volpe S, Belgioia L, Dionisi F, Romanello DA, Fallai C, Miceli R.

Head Neck. 2019 Oct;41(10):3684-3692. doi: 10.1002/hed.25890. Epub 2019 Jul 29.

PMID:
31355972
9.

Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression?

Orlandi E, Iacovelli NA, Cavallo A, Resteghini C, Gandola L, Licitra L, Bossi P.

Head Neck. 2019 Oct;41(10):3733-3735. doi: 10.1002/hed.25848. Epub 2019 Jul 17. No abstract available.

PMID:
31313409
10.

Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up.

Imbimbo M, Alfieri S, Botta L, Bergamini C, Gloghini A, Calareso G, Orlandi E, Iacovelli NA, Guzzo M, Granata R, Resteghini C, Locati L, Volpi CC, Licitra L, Bossi P.

Otolaryngol Head Neck Surg. 2019 Oct;161(4):635-642. doi: 10.1177/0194599819860808. Epub 2019 Jul 9.

PMID:
31286827
11.

The day after De-ESCALaTE and RTOG 1016 trials results.

Orlandi E, Licitra L.

Future Oncol. 2019 Jun;15(18):2069-2072. doi: 10.2217/fon-2019-0168. Epub 2019 Jun 26. No abstract available.

12.

Treatment Patterns in Patients with Chronic-Phase Chronic Myeloid Leukaemia in Routine Clinical Practice: the SIMPLICITY Italian Population.

Abruzzese E, Bosi A, Breccia M, D'Adda M, Di Renzo N, Liberati AM, Porrini R, Orlandi EM, Pane F, Pungolino E, Sorà F, Stagno F, Sen GP, Gentilini F, De Solda F, Gambacorti-Passerini C.

Mediterr J Hematol Infect Dis. 2019 May 1;11(1):e2019025. doi: 10.4084/MJHID.2019.025. eCollection 2019.

13.

Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience.

Cavanna L, Stroppa EM, Citterio C, Mordenti P, Di Nunzio C, Peveri S, Orlandi E, Vecchia S.

Onco Targets Ther. 2019 Apr 23;12:3077-3085. doi: 10.2147/OTT.S200754. eCollection 2019.

14.

Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?

Bonomo P, Greto D, Desideri I, Loi M, Di Cataldo V, Orlandi E, Iacovelli NA, Becherini C, Visani L, Salvestrini V, Mariotti M, Livi L.

Oral Oncol. 2019 Jun;93:1-7. doi: 10.1016/j.oraloncology.2019.04.006. Epub 2019 Apr 8.

PMID:
31109688
15.

Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.

Caocci G, Mulas O, Abruzzese E, Iurlo A, Annunziata M, Orlandi EM, Galimberti S, Binotto G, Sgherza N, Luciano L, Martino B, Russo Rossi A, Bonifacio M, Fozza C, Trawinska MM, Cattaneo D, Elena C, Baratè C, De Gregorio F, Molica M, La Nasa G, Foà R, Breccia M.

Ann Hematol. 2019 Aug;98(8):1885-1890. doi: 10.1007/s00277-019-03705-y. Epub 2019 May 1.

PMID:
31044260
16.

Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention.

Caocci G, Mulas O, Bonifacio M, Abruzzese E, Galimberti S, Orlandi EM, Iurlo A, Annunziata M, Luciano L, Castagnetti F, Gozzini A, Stagno F, Binotto G, Pregno P, Albano F, Martino B, Fozza C, Scaffidi L, Trawinska MM, Baratè C, Elena C, Cattaneo D, Scalzulli E, La Nasa G, Foà R, Breccia M.

Int J Cardiol. 2019 Aug 1;288:124-127. doi: 10.1016/j.ijcard.2019.04.051. Epub 2019 Apr 17.

PMID:
31029498
17.

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.

Caocci G, Mulas O, Abruzzese E, Luciano L, Iurlo A, Attolico I, Castagnetti F, Galimberti S, Sgherza N, Bonifacio M, Annunziata M, Gozzini A, Orlandi EM, Stagno F, Binotto G, Pregno P, Fozza C, Trawinska MM, De Gregorio F, Cattaneo D, Albano F, Gugliotta G, Baratè C, Scaffidi L, Elena C, Pirillo F, Scalzulli E, La Nasa G, Foà R, Breccia M.

Hematol Oncol. 2019 Aug;37(3):296-302. doi: 10.1002/hon.2606. Epub 2019 Apr 17.

18.

Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk.

Orlandi E, Zanot C, Poli A, Nicolis M, Rodolfo M, Turco A, Sangalli A, Gomez-Lira M.

Melanoma Res. 2019 Mar 20. doi: 10.1097/CMR.0000000000000605. [Epub ahead of print]

PMID:
30870271
19.

Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.

Trignani M, Argenone A, Di Biase S, Musio D, Merlotti A, Ursino S, Orlandi E, Genovesi D, Bacigalupo A.

Radiol Med. 2019 Jul;124(7):682-692. doi: 10.1007/s11547-019-01006-y. Epub 2019 Mar 9.

PMID:
30852793
20.

A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes.

De Cecco L, Serafini MS, Facco C, Granata R, Orlandi E, Fallai C, Licitra L, Marchesi E, Perrone F, Pilotti S, Quattrone P, Piazza C, Sessa F, Turri-Zanoni M, Battaglia P, Castelnuovo P, Antognoni P, Canevari S, Bossi P.

Oral Oncol. 2019 Mar;90:94-101. doi: 10.1016/j.oraloncology.2019.02.003. Epub 2019 Feb 11.

21.

Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial.

Borghi L, Galimberti S, Baratè C, Bonifacio M, Capochiani E, Cuneo A, Falzetti F, Iurlo A, Lunghi F, Minotto C, Orlandi EM, Rege-Cambrin G, Sica S, Supekar S, Haenig J, Vegni E.

Front Psychol. 2019 Feb 20;10:329. doi: 10.3389/fpsyg.2019.00329. eCollection 2019.

22.

The dilemma of metastatic medullary thyroid carcinoma: when to start systemic treatment.

Siano M, Alfieri S, Granata R, Calareso G, Orlandi E, Bergamini C, Locati LD.

Tumori. 2019 Feb 19:300891619829571. doi: 10.1177/0300891619829571. [Epub ahead of print]

PMID:
30782103
23.

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis.

Cavanna L, Citterio C, Orlandi E.

Oncotarget. 2019 Jan 4;10(2):209-215. doi: 10.18632/oncotarget.26541. eCollection 2019 Jan 4.

24.

Prevalence of Fatigue in Head and Neck Cancer Survivors.

Bossi P, Di Pede P, Guglielmo M, Granata R, Alfieri S, Iacovelli NA, Orlandi E, Guzzo M, Bianchi R, Ferella L, Infante G, Miceli R, Licitra L, Ripamonti CI.

Ann Otol Rhinol Laryngol. 2019 May;128(5):413-419. doi: 10.1177/0003489419826138. Epub 2019 Jan 30.

PMID:
30700107
25.

Radiation-induced papillary thyroid cancer: is it a distinct clinical entity?

Bresciani L, Orlandi E, Piazza C.

Curr Opin Otolaryngol Head Neck Surg. 2019 Apr;27(2):117-122. doi: 10.1097/MOO.0000000000000522. Review.

PMID:
30664052
26.

Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.

Alessi A, Lorenzoni A, Cavallo A, Padovano B, Iacovelli NA, Bossi P, Alfieri S, Serafini G, Colombo CB, Cicchetti A, Mira M, Licitra L, Fallai C, Crippa F, Orlandi E.

Radiol Med. 2019 May;124(5):414-421. doi: 10.1007/s11547-018-0980-6. Epub 2018 Dec 17.

PMID:
30560502
27.

Expression of TLR4-PTGE2 signaling genes in atherosclerotic carotid plaques and peripheral blood.

Ferronato S, Scuro A, Fochi S, Orlandi E, Gomez-Lira M, Olivato S, Mazzucco S, Turco A, Romanelli MG.

Mol Biol Rep. 2019 Feb;46(1):1317-1321. doi: 10.1007/s11033-018-4478-z. Epub 2018 Nov 12.

PMID:
30421129
28.

Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients.

Orlandi E, Iacovelli NA, Rancati T, Cicchetti A, Bossi P, Pignoli E, Bergamini C, Licitra L, Fallai C, Valdagni R, Cavallo A.

Oral Oncol. 2018 Nov;86:266-272. doi: 10.1016/j.oraloncology.2018.10.006. Epub 2018 Oct 11.

PMID:
30409311
29.

Big Data in Head and Neck Cancer.

Resteghini C, Trama A, Borgonovi E, Hosni H, Corrao G, Orlandi E, Calareso G, De Cecco L, Piazza C, Mainardi L, Licitra L.

Curr Treat Options Oncol. 2018 Oct 25;19(12):62. doi: 10.1007/s11864-018-0585-2. Review.

PMID:
30361937
30.

Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes.

Scarpi E, Dall'Agata M, Zagonel V, Gamucci T, Bertè R, Sansoni E, Amaducci E, Broglia CM, Alquati S, Garetto F, Schiavon S, Quadrini S, Orlandi E, Casadei Gardini A, Ruscelli S, Ferrari D, Pino MS, Bortolussi R, Negri F, Stragliotto S, Narducci F, Valgiusti M, Farolfi A, Nanni O, Rossi R, Maltoni M; Early Palliative Care Italian Study Group (EPCISG).

Support Care Cancer. 2019 Jul;27(7):2425-2434. doi: 10.1007/s00520-018-4517-2. Epub 2018 Oct 24.

PMID:
30357555
31.

In Reply to Fakhry et al.

Bossi P, Miceli R, Granata R, Naimo S, Infante G, Locati LD, Iacovelli NA, Fallai C, Orlandi E, Licitra L.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):670-671. doi: 10.1016/j.ijrobp.2018.06.019. No abstract available.

PMID:
30238903
32.

Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial.

Casadei Gardini A, Scarpi E, Orlandi E, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Ruscelli S, Vespignani R, Ronconi S, Frassineti GL, Amadori D, Passardi A.

Onco Targets Ther. 2018 Aug 29;11:5261-5268. doi: 10.2147/OTT.S166614. eCollection 2018.

33.

Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis.

Citterio C, Baccini M, Orlandi E, Di Nunzio C, Cavanna L.

Oncotarget. 2018 Jul 3;9(51):29801-29809. doi: 10.18632/oncotarget.25639. eCollection 2018 Jul 3.

34.

Lipid-poor adrenal adenoma versus metastasis in lung cancer: Diagnosis by "comparative enhancement" at multiphasic MR imaging.

Scialpi M, D'Andrea A, Rondoni V, Orlandi E, Bernardini S, Napoletano M, Pusiol T.

Lung India. 2018 Jul-Aug;35(4):364-366. doi: 10.4103/lungindia.lungindia_6_18. No abstract available.

35.

Correction to: Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature.

Ambroggi M, Biasini C, Toscani I, Orlandi E, Berte R, Mazzari M, Cavanna L.

Support Care Cancer. 2018 Sep;26(9):2955. doi: 10.1007/s00520-018-4303-1. No abstract available.

PMID:
29948394
36.

Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer.

Orlandi E, Miceli R, Infante G, Mirabile A, Alterio D, Cossu Rocca M, Denaro N, Vigna-Taglianti R, Merlotti A, Schindler A, Pizzorni N, Fallai C, Licitra L, Bossi P.

Dysphagia. 2019 Feb;34(1):52-62. doi: 10.1007/s00455-018-9913-8. Epub 2018 Jun 8.

37.

What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis.

Bonomo P, Merlotti A, Olmetto E, Bianchi A, Desideri I, Bacigalupo A, Franco P, Franzese C, Orlandi E, Livi L, Caini S.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2122-2138. doi: 10.1007/s00259-018-4065-5. Epub 2018 Jun 9. Review.

38.

Chronic myeloproliferative neoplasms in the elderly.

Maffioli M, Orlandi E, Passamonti F.

Eur J Intern Med. 2018 Dec;58:33-42. doi: 10.1016/j.ejim.2018.05.005. Epub 2018 May 22. Review.

PMID:
29793825
39.

Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers.

Resteghini C, Perrone F, Miceli R, Bergamini C, Alfieri S, Orlandi E, Guzzo M, Granata R, Galbiati D, Cavalieri S, Locati L, Licitra L, Bossi P.

Tumori. 2018 Jun;104(3):213-220. doi: 10.1177/0300891618765558. Epub 2018 Apr 18.

PMID:
29714670
40.

Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature.

Ambroggi M, Biasini C, Toscani I, Orlandi E, Berte R, Mazzari M, Cavanna L.

Support Care Cancer. 2018 Sep;26(9):2945-2953. doi: 10.1007/s00520-018-4184-3. Epub 2018 Apr 27. Review. Erratum in: Support Care Cancer. 2018 Jun 11;:.

41.

The effects of psychoeducational family intervention on coping strategies of relatives of patients with bipolar I disorder: results from a controlled, real-world, multicentric study.

Sampogna G, Luciano M, Del Vecchio V, Malangone C, De Rosa C, Giallonardo V, Borriello G, Pocai B, Savorani M, Steardo L Jr, Lampis D, Veltro F, Bartoli F, Bardicchia F, Moroni AM, Ciampini G, Orlandi E, Ferrari S, Biondi S, Iapichino S, Pompili E, Piselli M, Tortorella A, Carrà G, Fiorillo A.

Neuropsychiatr Dis Treat. 2018 Apr 11;14:977-989. doi: 10.2147/NDT.S159277. eCollection 2018.

42.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L, Perez AM, Coscia M, Laurenti L, Musuraca G, Farina L, Delgado AR, Orlandi EM, Galieni P, Mauro FR, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, Eyre TA, Kennedy B, Bowles KM, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P; GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum.

Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

43.

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.

Caocci G, Mulas O, Annunziata M, Luciano L, Bonifacio M, Orlandi EM, Pregno P, Galimberti S, Russo Rossi A, Abruzzese E, Iurlo A, Martino B, Sgherza N, Binotto G, Castagnetti F, Gozzini A, Fozza C, Bocchia M, Sicuranza A, Stagno F, Efficace F, Usala E, De Gregorio F, Scaffidi L, Elena C, Pirillo F, Baratè C, Trawinska MM, Cattaneo D, Labate C, Gugliotta G, Molica M, Specchia G, La Nasa G, Foà R, Breccia M.

Am J Hematol. 2018 Jul;93(7):E159-E161. doi: 10.1002/ajh.25102. Epub 2018 Apr 28. No abstract available.

44.

Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia.

Pungolino E, Rossi G, De Canal G, Trojani A, D'adda M, Perego A, Orlandi EM, Lunghi F, Turrini M, Borin L, Iurlo A, Latargia ML, Carraro MC, Spina F, Lodola M, Artale S, Anghilieri M, Spedini P, Cantoni S, Di Camillo B, Morra E, Cairoli R.

Am J Hematol. 2018 Jul;93(7):E162-E164. doi: 10.1002/ajh.25106. Epub 2018 May 17. No abstract available.

45.

Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status.

Cavanna L, Seghini P, Di Nunzio C, Orlandi E, Michieletti E, Stroppa EM, Mordenti P, Citterio C, Vecchia S, Zangrandi A.

Oncol Lett. 2018 Apr;15(4):5787-5791. doi: 10.3892/ol.2018.8054. Epub 2018 Feb 14.

46.

Solitary pulmonary nodule: Increasing diagnosis and accuracy of biopsy by biparametric MR imaging.

Scialpi M, Malaspina CM, Rondoni V, Orlandi E, Coppola L, Pusiol T, Palumbo B.

Lung India. 2018 Mar-Apr;35(2):182-183. doi: 10.4103/lungindia.lungindia_424_17. No abstract available.

47.

Treatment challenges in and outside a network setting: Head and neck cancers.

Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):40-45. doi: 10.1016/j.ejso.2018.02.007. Epub 2018 Feb 14. Review.

PMID:
29478741
48.

Failure of Further Validation for Survival Nomograms in Oropharyngeal Cancer: Issues and Challenges.

Bossi P, Miceli R, Granata R, Naimo S, Infante G, Locati LD, Iacovelli NA, Fallai C, Licitra L, Orlandi E.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1217-1221. doi: 10.1016/j.ijrobp.2017.12.281. Epub 2017 Dec 28.

PMID:
29395630
49.

Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer'.

Bossi P, Granata R, Orlandi E, Licitra L.

Br J Cancer. 2018 Feb 6;118(3):e5. doi: 10.1038/bjc.2017.416. Epub 2018 Jan 23. No abstract available.

50.

Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO).

Maddalo M, Bonomo P, Belgioia L, Bacigalupo A, Donato V, Alterio D, Orlandi E, Argenone A, Merlotti A, Musio D, Trignani M, Ursino S, Arcangeli S, Furlan C, Osti MF; Italian Association of Radiation Oncology (AIRO).

Eur Arch Otorhinolaryngol. 2018 Feb;275(2):561-567. doi: 10.1007/s00405-017-4853-8. Epub 2017 Dec 26.

PMID:
29279949

Supplemental Content

Loading ...
Support Center